Semaglutide's once-a-week injection is a great choice for patients
However, a shocking new study published in JAMA Ophthalmology has raised serious concerns about their unexpected effects on eye health
Case reports and post-marketing data have documented various cutaneous reactions in patients taking GLP-1 receptor agonists, including urticaria, rash, and pruritus
In the LIVE trial, Liraglutide did not show an improvement in left ventricular ejection fraction (LVEF) in a 24-week period in ambulatory patients affected by HF LVEF lower than 45%
Verify the most current contact details on the official website, as business addresses and contact information may be updated
Green, from UCSFs Departments of Neurology and Ophthalmology and the Weill Institute for Neurosciences, says the findings raise concerns about current B12 recommendations